Anti-Parkinsons Flashcards
Drugs and Chemicals that may cause Parkinsons
Antipsychotics (Haloperidol)
MPTP
Alpha Synuclein Protein
Dopamine Precursor
L Dopa
Dopamine Receptor Antagonists
Pramipexole
Ropinirole
Bromocriptine
Apomorphine
MAOI
Selegiline
Rasagiline
COMT Inhibitors
Entacapone
Tolcapone
Dopamine Facilitators
Amantadine
CNS Anticholinergic Agents
Benztropine
Trihexyphenidyl
Carbidopa
- Inhibits DOPA Decarboxylase BUT cannot cross BBB
DOPA Decarboxylase Co-Factor
Pyridoxine
L Dopa
- Prodrug of Dopamine
- Stimulates D2 receptors
PHARMACOKINETICS: Mostly metabolized cereberally, given in combo w/ Carbidopa to prevent peripheral metabolism
L Dopa: Clinical & Pharmacologic Effects
CLINICAL
- Best Results in first few years of Tx
- Works faster on rigidity and bradykinesia than on tremor
PHARMACOLOGIC
- Tolerance to effects builds up after 5 years
- Effective in relieving Bradykinesia
L Dopa: GI Effects
- Anorexia, Nausea/Vomiting at first (tolerance builds up)
- Avoid Antiemetics
- GI effects less frequent w/ L Dopa/Carbidopa combo
L Dopa: SE
CVS - Arrhythmias, Tachycardia, postural hypotension BEHAVIORAL - Depression, Anxiety, Agitation, Insomnia, Confusion, Hallucinations, Nightmare, Euphoria DYSKINESIA - Choreoathetosis RESPONSE FLUCTUATIONS - Wearing-off Rxns (End Dose Akinesia) - On-Off Phenomena MISC - Mydriasis, Glaucoma (maybe) - Brown saliva, urine, vaginal secretions
L DOPA: Drug Interactions and CI
DRUG INTERACTIONS
- L DOPA + MAOI = HTN Crisis, Hyperpyrexia
- L DOPA + Pyridoxine = Peripheral conversion of L DOPA to Dopamine
- Antiemetics = Block Dopamine Receptors
CI
- Psychotic Pts
- Angle Closure Glaucoma
- Peptic Ulcer
- Melanoma& Skin Lesions
Carbidopa
- DOPA Decarboxylase Inhibitors
- Can’t Breach BBB
- Usually Combo w/ L DOPA
MPTP
- Cause irreversible damage to nigrostriatal neurons
Dopamine Receptor Agonists
- Bromocriptine: D2 agonist (Valve Fibrosis)
- Pramipexole: D3 agonist, Used in Advanced Parkinsons, scavenge hydrogen peroxide
- Ropinirole: Pure D2 Receptor Agonist
- Apomorphine: Potent Dopamine Agonist, quick relief of off-periods of akinesia
SE: May enhance SE of L DOPA
COMT Inhibitor
Tolcapone Entacapone - Inhibit L DOPA Peripheral Metabolism - Good for pts w/ Response fluctuation SE: Orange Urine, INC Liver enzymes (Hepatic Failure)
Amantadine
- Antiviral
- May potentiate INC in Dopamine synth, release or reuptake
SE: Liveto Reticularis
M Receptor Antagonist
Benztropine
Trihexyphenidyl
Diphenhydramine
- Tx of Drug Induced Dyskinesia
- Helps Tremor and Dyskinesia but not Bradykinesia
SE: Agitation, Confusion, Constipation, Delirium, Dry mouth, Memory Loss, Urinary retention, Tachycardia
Parkinsons Vaccine
- Immune response against Aggregated Alpha-Synuclein
Restless Leg Syndrome Rx
Pramipexole Ropinirole Diazepam Gabapentin Opiates
Wilson’s Disease Rx
Penicillamine
Trientine
Tetrathiomolybdate
Zinc
ALS Rx
Baclofen
Tizanidine
Gabapentin
Riluzole
MS Rx
Interferons Natalizumab Mitoxantrone Glatiramer Fingolimod Dalfampridine
Alzheimer’s Rx
- Acetylcholine Esterase Inhibitors Rivastigmine Donepezil Gallantamine Tacrine - Glutamate Receptor Antagonists Memantine
Huntington’s Rx
- Tetrabenazine & Reserpine (Inhibit VMAT = limit dopamine vesicle packaging and release
- Haloperidol